[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370809-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370809-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-comparative-burden-of-brain-and-central-nervous-system-cancers-from-1990-to-2021-between-china-the-united-states-the-united-kingdom-and-japan","The comparative burden of brain and central nervous system cancers from 1990 to 2021 between China, the United States, the United Kingdom, and Japan","","Brain and central nervous system (CNS) cancers impose a substantial, increasing disease burden in China, with elevated mortality and disability that exceeds that of several developed settings. Evidence on disparities in cancer control approaches between China and countries such as the US, UK, and Japan is used to support policy improvements. Global Burden of Disease (GBD) 2021 data quantify incidence, prevalence, mortality, and DALYs trends from 1990–2021, assess inequalities, and project future patterns.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-comparative-burden-of-brain-and-central-nervous-system-cancers-from-1990-to-2021-between-china-the-united-states-the-united-kingdom-and-japan/370809/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-comparative-burden-of-brain-and-central-nervous-system-cancers-from-1990-to-2021-between-china-the-united-states-the-united-kingdom-and-japan/370809.png","ImageObject",300,407,{"name":42,"@type":43},"Dipper","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",16,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What overall trend did the analysis find for China from 1990 to 2021 in incidence and mortality?","Question",{"text":63,"@type":64},"Age-standardized incidence (ASIR) and prevalence (ASPR) increased across 1990–2021, while age-standardized mortality (ASMR) and DALYs (ASDR) declined in China over the same period.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do China’s 2021 disease-burden figures compare with the US, UK, and Japan?",{"text":68,"@type":64},"In 2021, China reported 105,541 new cases and 68,911 deaths. China showed lower age-standardized incidence and prevalence than comparison nations, but its DALYs rate was higher, indicating comparatively greater impact.",{"name":70,"@type":61,"acceptedAnswer":71},"How were health inequalities and future trends projected in this study?",{"text":72,"@type":64},"Health inequalities were measured using the Slope Inequality Index (SII) and Concentration Index, while future trends were projected using ARIMA models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370809,1790387693,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":113,"preview_page_count":33,"preview_urls":146},1374404997633,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Li etal. BMC Public Health (2025) 25:2670 BMC Public Health  \n[https://doi.org/10.1186/s12889-025-23982-9](https://doi.org/10.1186/s12889-025-23982-9)  \nRESEARCH Open Access  \nThe comparative burden of brain and central  nervous system cancers from 1990 to 2021 between China, the United States, the United Kingdom, and Japan  \nZirui Li 1†, Xin Chen 1,2†, Shuai Han 1* and Anhua Wu 1,2*  \nAbstract  \nBackground Brain and central nervous system (CNS) cancers impose a substantial and growing disease burden in China, marked by elevated mortality and disability rates. Understanding disparities in cancer control strategies between China and developed countries (the US, the UK, and Japan) may inform evidence-based policy improvements.  \nMethods Using Global Burden of Disease (GBD) 2021 data, we analyzed incidence, prevalence, mortality, and disability-adjusted life years (DALYs) for brain and CNS cancers (1990–2021) . Trends were assessed via estimated annual percentage change (EAPC), while frontier analysis evaluated disease burden reduction capacity relative to socioeconomic development. Health inequalities were measured using the Slope Inequality Index (SII) and Concentration Index. Future trends were projected via ARIMA models.  \nResults In 2021, China reported 105,541 new cases and 68,911 deaths. While China had lower age-standardized incidence (ASIR) and prevalence (ASPR) rates than comparison nations, its DALYs rate was higher. From 1990 to 2021, ASIR and ASPR increased universally, whereas age-standardized mortality (ASMR) and DALYs (ASDR) declined in China, the US, and the UK but rose in Japan. High-SDI regions exhibited greater burden mitigation capacity, with widening cross-country inequalities. Projections indicate rising ASIR in all nations by 2036.  \nConclusions Despite declining mortality, China’s brain and CNS cancer burden remains disproportionately high. Policymakers should integrate effective strategies from developed nations while tailoring interventions to China’s unique epidemiological and healthcare context.  \nKeywords Brain and CNS cancers, Epidemiology, Global burden of disease, Disability-adjusted life years, Health inequality, Prediction, China, The united states, The united kingdom, Japan  \n†Zirui Li and Xin Chen contributed equally to this work.  \n*Correspondence:  \nShuai Han [hanshuai19870217@outlook.com](hanshuai19870217@outlook.com)[ ](hanshuai19870217@outlook.com)Anhua Wu  \n[ahwu@cmu.edu.cn](ahwu@cmu.edu.cn)  \n1Department of Neurosurgery, Shengjing Hospital of China Medical University, No. 36, Sanhao Street, Heping District, Shenyang 110004, Liaoning, China  \n2Institute of Health Sciences, China Medical University, Shenyang, Liaoning, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nLi et al. BMC Public Health (2025) 25:2670  \nIntroduction  \nBrain and central nervous system (CNS) cancers represent a heterogeneous group of malignancies with distinct histopathological and molecular features. These neoplasms originate from neuroepithelial tissues (e.g., gliomas), meninges (e.g., meningiomas), and other neural structures, exhibiting a broad spectrum of biolog","cbCaie5pErf3GbEi","https://ap.wps.com/l/cbCaie5pErf3GbEi","pdf",5544661,12,"English","# Abstract\n# Introduction\n## Background and significance\n## Risk factors and prevention context\n## Geographic variation and China as a case study","[{\"question\":\"What overall trend did the analysis find for China from 1990 to 2021 in incidence and mortality?\",\"answer\":\"Age-standardized incidence (ASIR) and prevalence (ASPR) increased across 1990–2021, while age-standardized mortality (ASMR) and DALYs (ASDR) declined in China over the same period.\"},{\"question\":\"How do China’s 2021 disease-burden figures compare with the US, UK, and Japan?\",\"answer\":\"In 2021, China reported 105,541 new cases and 68,911 deaths. China showed lower age-standardized incidence and prevalence than comparison nations, but its DALYs rate was higher, indicating comparatively greater impact.\"},{\"question\":\"How were health inequalities and future trends projected in this study?\",\"answer\":\"Health inequalities were measured using the Slope Inequality Index (SII) and Concentration Index, while future trends were projected using ARIMA models.\"}]","The comparative burden of brain and central nervous system cancers from 1990 to 2021 between China, the United States, the United Kingdom, and Japan | PDF",1790190458,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da25162370c60e901cf3519d72ccc054.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/81679f4c68fd6ea351e9ff940a8f6d44.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/38ec6475599fc8d946df092024dc0073.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da540902aa3d9350f3bf44e9fc8786d8.webp",980,1306]